Genetesis Announces New Scientific Advisory Board 🧪

Published on
August 26, 2021
Business Wire
A Berkshire Hathaway Company

Genetesis, the market leader in the design, development and commercialization of biomagnetic imaging solutions, today announced its new Scientific Advisory Board (SAB). The group is comprised of world-class experts, researchers and thought leaders spanning cardiology, emergency medicine and radiology. The newly appointed SAB will play a key role in helping to shape the company’s product and commercial roadmap, clinical strategy and R&D activities.